cabergoline has been researched along with Apoplexy, Pituitary in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dekkers, OM; Fleseriu, M; Karavitaki, N | 1 |
| Biermasz, NR; Chanson, P; Jorgensen, JOL; Kuhn, E; Weinreich, AA | 1 |
| Ach, K; Ach, T; Ben Abdelkrim, A; Chaieb, M; Elfekih, H; Hasni, Y; Kacem, M; Khaldi, S; Maaroufi, A; Saad, G | 1 |
| Chin, M; Ishibashi, R; Kurosaki, Y; Maki, Y; Uchino, K; Yamagata, S | 1 |
| Chng, E; Dalan, R | 1 |
| Cleemann, L; Holm, K; Jarløv, AE; Lewis, A | 1 |
| Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA | 1 |
| Pobereskin, L; Vaidya, B; Watt, A | 1 |
| Ball, SG; Connolly, V; James, RA; Kane, P; Kelly, WF; Kendall-Taylor, P; Mathias, D; Perros, P; Quinton, R; Sibal, L; Vaidya, B | 1 |
| Balarini Lima, GA; Dos Santos Silva, CM; Filho, PN; Gadelha, MR; Machado, Ede O | 1 |
| Allen, K; Byrne, JV; Cudlip, S; De Silva, SR; Soni, A; Wass, JA | 1 |
| De Tommasi, A; De Tommasi, C; Guastamacchia, E; Losa, M; Luzzi, S; Resta, F; Sabbà, C; Tafaro, E; Terreni, MR; Triggiani, V | 1 |
2 review(s) available for cabergoline and Apoplexy, Pituitary
| Article | Year |
|---|---|
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Tumor Burden; Young Adult | 2021 |
Pituitary apoplexy associated with cabergoline therapy.
Topics: Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Humans; Male; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Young Adult | 2013 |
10 other study(ies) available for cabergoline and Apoplexy, Pituitary
| Article | Year |
|---|---|
Endocrinology in the time of COVID-19: Management of pituitary tumours.
Topics: Adenoma; Antineoplastic Agents, Hormonal; Cabergoline; Coronavirus Infections; COVID-19; Disease Management; Dopamine Agonists; Hormone Replacement Therapy; Human Growth Hormone; Humans; Neurosurgical Procedures; Octreotide; Pandemics; Peptides, Cyclic; Pituitary Apoplexy; Pituitary Neoplasms; Pneumonia, Viral; Practice Guidelines as Topic; Radiotherapy; Somatostatin; Telemedicine; Time Factors; Visual Field Tests | 2020 |
Pituitary apoplexy of a giant prolactinoma during pregnancy.
Topics: Adult; Cabergoline; Cytoreduction Surgical Procedures; Fatal Outcome; Female; Humans; Infertility; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Premature Birth; Prolactin; Prolactinoma | 2021 |
Pituitary Apoplexy in Long-Term Cabergoline User During Thrombocytopenia Due to Chemotherapy for Chronic Myelocytic Leukemia.
Topics: Cabergoline; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Long-Term Care; Magnetic Resonance Imaging; Middle Aged; Neuroendoscopy; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Thrombocytopenia; Tomography, X-Ray Computed | 2018 |
[Pituitary apoplexy in a young woman].
Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms | 2014 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders | 2015 |
Pituitary apoplexy within a macroprolactinoma.
Topics: Antineoplastic Agents; Cabergoline; Diagnosis, Differential; Ergolines; Female; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 2008 |
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cabergoline; Combined Modality Therapy; Decompression, Surgical; Ergolines; Female; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Gland; Pituitary Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vision Disorders | 2004 |
Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.
Topics: Adolescent; Adult; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 2008 |
A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
Topics: Angiography, Digital Subtraction; Antineoplastic Agents; Balloon Occlusion; Cabergoline; Carotid Artery, Internal; Dopamine Agonists; Ergolines; Headache; Humans; Intracranial Aneurysm; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Ophthalmoplegia; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Treatment Outcome; Vision Disorders | 2008 |
Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report.
Topics: Adult; Cabergoline; Carcinoma; Combined Modality Therapy; Disease Progression; Dopamine Agonists; Drug Resistance; Ergolines; Fatal Outcome; Female; Humans; Octreotide; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Subarachnoid Hemorrhage | 2007 |